Who we are

Founded on the premise to radically improve healthcare the team set out to develop a MEMS based microneedle chip for extraction of dermal interstitial fluid (dISF).
After almost 10 years of developing a system, the company is now entering into numerous clinical trials with the aim of characterizing both the system and dISF in itself.

How do we work?

Ascilion collaborates with organizations within fields as vast and diverse as oncology and neonatal. But the common denominator is always a need for a modern day syringe and a curiosity and drive on how to enhance health science at large.
Sampling of dISF has never been easier with on-screen monitoring, precise sub-pressure control and pre-defined sampling sequences.

How it began

Ascilion was founded in 2012 with a mission to solve the problem of extracting dermal interstitial fluid (dISF) in a timely and pain-free way. A team of engineers with a thorough understanding of MEMS technology and micro fluidics took on the challenge of solving what turned out to be a very complex problem.

Terms And Conditions / Privacy Shield Statement

Open our Website Terms of Use in PDF-format

Regulatory disclaimer

The system and devices described and depicted on this website are not regulatory approved. Neither the system nor the devices are allowed for use outside clinical studies where approval for use has been obtained by appropriate authorities.

Do you still want to use it – We’ll work with you creating the documentation needed for submission of the application of your study.

Cookie, anyone?

Ascilion’s website uses cookies. A cookie is a text file that the website you visit requests to save on your computer. Ascilion uses cookies based on your consent to:

  • Facilitate and improve your use of the website.
  • Collect information about your experience on our website using Google Analytics. Such information includes number of website visitors, average duration per session, the pages per session, and more.
  • Identify when business contacts visit our website.
  • Engage in marketing: Display Ascilion’s advert when you visit certain websites, including but not limited to Facebook, LinkedIn, Twitter, Instagram, Google, and to create social media marketing profiles based on the information collected via cookies, assess marketing performance to create better marketing campaigns.

If you do not wish to receive cookies, the “Help” portion of the toolbar on most browsers will tell you how to prevent your browser from accepting new cookies or how to have the browser notify you when you receive a new cookie. Additionally, you may be able to disable or delete similar data used by browser add-ons, such as Flash cookies, by changing the add-on’s settings or visiting the website of its manufacturer. You may, further, receive a direct prompt from Ascilion’s website wherein you can opt out of or otherwise modify any cookie settings.

Cookie Declaration

Lorum ipsum

Lorum ipsum dolor sit amet. Sed dium nonum nibb euismod tincidunt ut laorect dolore magna aliquam erat volutpat. Ust wist enim ad minim. Venium quis nostrud exertci tation. Lorum ipsum dolor sit amet. Sed dium nonum nibb euismod tincidunt ut laorect dolore magna aliquam erat volutpat.

Get in touch

Contact us